Consensus Guidelines for the Management of Tissue Filler–Induced Vision Loss in the United Kingdom

Worldwide, the use of soft tissue fillers for aesthetic purposes has significantly increased, as have the number of associated complications. Vision loss is a rare but catastrophic complication of injecting tissue fillers. We formed a UK multidisciplinary steering group in 2024 to develop consensus guidelines for the management of tissue filler-induced vision loss. The multidisciplinary steering group consisted of various specialists with significant expertise in aesthetics, emergency ophthalmology, oculoplastic surgery, and the retina. Consensus statements were formulated by the group. Recommendations focused on immediate emergency measures, access pathways to specialist care, improved consent processes, and increasing awareness of vision-related complications. These guidelines aim to provide pragmatic, evidence-based steps for frontline clinicians to optimize patient outcomes for this rare but devastating complication. Level of Evidence: 5 (Risk).